Side-by-side comparison of AI visibility scores, market position, and capabilities
San Francisco AI that virtualizes clinic front desk, medical assistant, and scribe functions for on-demand virtual clinics; YC-backed at $2.3M revenue with EHR integration generating $1M new revenue for average clinic.
Ankr Health is a San Francisco-based healthcare technology company using generative AI to virtualize clinic infrastructure — automating front desk operations, medical assistant workflows, and clinical documentation (AI scribe functions) that enable physicians to launch on-demand virtual and hybrid clinics without the full overhead of physical clinic staff. Founded in 2022 and backed by Y Combinator with $500,000 raised from MedTech Innovator, WorldQuant Ventures, and YC, Ankr Health generated $2.3 million in revenue in 2024 with a 15-person team, with integration across all major EHR systems (Epic, Cerner, athenahealth) and a reported $1 million in new annual revenue generated for average clinic customers.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.